[Biological trials of physiologically active compounds (the methodology). II].
Landau
M A
MA
D000818:Animals; D004194:Disease / Q000209:etiology; D015195:Drug Design; D004353:Drug Evaluation, Preclinical / Q000379:methods*; D004358:Drug Therapy / Q000379:methods; D064420:Drug-Related Side Effects and Adverse Reactions